Physician profile
Eric P Bachelor
NPI 1831121862
$232,668.47
in general payments reported to CMS, 2019-2025
10 companies · $5,695 in 2025
The $5,695 reported for 2025 was more than what 93% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $327 · 2021: $91K · 2022: $105K · 2023: $10K · 2024: $5,355 · 2025: $5,695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,287 · Food and Beverage: $1,240 · Education: $16.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,810.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,286.85 |
| Food and Beverage | $1,239.86 |
| Education | $16.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $197,730.76 | 2019-2023 | |
| Abbvie INC. | $33,415.93 | 2022-2025 | Natrelle Saline-Filled Breast Implants, Botox, Alloderm |
| Apyx Medical Corporation | $390.93 | 2019-2020 | |
| Sientra, INC. | $272.39 | 2019-2022 | |
| Revance Therapeutics, INC. | $226.53 | 2025 | Daxxify |
| Galderma Laboratories, L.P. | $212.15 | 2019 | |
| Tela Bio, INC. | $194.74 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Mentor Worldwide LLC | $132.99 | 2019-2020 | |
| Motiva USA, LLC | $75.43 | 2025 | |
| Medtronic, INC. | $16.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Bachelor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.